Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsing-remitting Multiple Sclerosis (rrMS)”

183 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 183 results

Large-scale testing (Phase 3)Study completedNCT01838668
What this trial is testing

An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-Remitting Multiple SclerosisMultiple Sclerosis
Biogen 225
Early research (Phase 1)Study completedNCT01738347
What this trial is testing

Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS).

Who this might be right for
Relapsing-remitting Multiple Sclerosis (rrMS)
GE Healthcare 30
Post-approval studies (Phase 4)Active Not RecruitingNCT05090371
What this trial is testing

Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Novartis Pharmaceuticals 136
Not applicableStudy completedNCT05684016
What this trial is testing

Assessment of Deep Gray Matter Anatomic Changes in RRMS Patients Treated With Gilenya® With and Without Cognitive Impairment Over a 2 Year Period Using NeuroQuant, NeuroQuarc and ANAM

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
George Washington University 75
Post-approval studies (Phase 4)Study completedNCT01534182
What this trial is testing

Evaluation of Patient Reported Outcomes in RRMS Patients Candidates for MS Therapy Change and Transitioned to Fingolimod 0.5 mg (EPOC)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 298
Post-approval studies (Phase 4)UnknownNCT00910598
What this trial is testing

Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Amphia Hospital 60
Early research (Phase 1)Ended earlyNCT01318421
What this trial is testing

ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Elan Pharmaceuticals 12
Testing effectiveness (Phase 2)UnknownNCT01466114
What this trial is testing

Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

Who this might be right for
Relapsing-remitting Multiple SclerosisSecondary-progressive Multiple SclerosisPrimary-progressive Multiple Sclerosis
University of California, Los Angeles 64
Large-scale testing (Phase 3)Ended earlyNCT01633112
What this trial is testing

MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone

Who this might be right for
Relapsing-remitting Multiple Sclerosis (RRMS)
Novartis Pharmaceuticals 1,064
Large-scale testing (Phase 3)Looking for participantsNCT06700343
What this trial is testing

Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

Who this might be right for
Relapsing-remitting Multiple Sclerosis (RRMS)
Amgen 444
Large-scale testing (Phase 3)Study completedNCT01307332
What this trial is testing

Advanced MRI Measures of Repair in Alemtuzumab Treated Patients

Who this might be right for
Relapsing Remitting Multiple Sclerosis
University of British Columbia 27
Post-approval studies (Phase 4)Study completedNCT01085318
What this trial is testing

Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial

Who this might be right for
Multiple Sclerosis
EMD Serono 38
Testing effectiveness (Phase 2)Study completedNCT00893217
What this trial is testing

BEYOND Pilot Study

Who this might be right for
Multiple SclerosisRelapsing-Remitting
Bayer 71
Testing effectiveness (Phase 2)Ended earlyNCT03239860
What this trial is testing

Assessing the HERV-W Env ANtagonist GNbAC1 for Evaluation in an Open Label Long-term Safety Study in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GeNeuro SA 220
Not applicableLooking for participantsNCT05510817
What this trial is testing

Multiparametric Assessment to Investigate Prognostic Factors for Disease Evolution a nd Evolutionary Patterns of Cognitive Status in RRMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
University Hospital of Mont-Godinne 50
Not applicableUnknownNCT05245344
What this trial is testing

Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Preclinical Study

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)Neuromyelitis OpticaHealthy
Neuromed IRCCS 154
Testing effectiveness (Phase 2)Study completedNCT01428726
What this trial is testing

A Phase IIa Study of NT-KO-003 for Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Neurotec Pharma 99
Testing effectiveness (Phase 2)Active Not RecruitingNCT06800404
What this trial is testing

"HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)Multiple Sclerosis
Hope Biosciences Research Foundation 10
Large-scale testing (Phase 3)Study completedNCT00428584
What this trial is testing

RNF and Betaseron® Tolerability Study

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)
EMD Serono 129
Post-approval studies (Phase 4)Study completedNCT01333501
What this trial is testing

Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 151
Load More Results